Vanda Pharm, OliPass partner to jointly develop antisense oligonucleotide
01 Oct 2022 //
PHARMABIZ
Vanda Pharmaceuticals, OliPass Enter ASO R&D Alliance
30 Sep 2022 //
CONTRACTPHARMA
OliPass Moves Forward to Second Stage of PIIa Trial for Pain Killer OLP-1002
18 Jul 2022 //
PRNEWSWIRE
OliPass begins dosing in Phase IIa trial of painkiller for osteoarthritis
22 Feb 2022 //
CLINICALTRIALSARENA